key topics
navigation
|
New Autoinjector Available
For Psoriatic And Rheumatic Diseases
New Products:
New Autoinjector Available
For Psoriatic And Rheumatic Diseases
-
|
|
For some patients who have arthritis in their hands, it can be difficult to administer a treatment injection.
With this in mind, Amgen and Wyeth Pharmaceuticals have developed the Enbrel® SureClick™ autoinjector for patients who suffer from psoriatic and rheumatic diseases.
The device recently garnered approval from the Food and Drug Administration (FDA). The manufacturer notes that the autoinjector also provides an alternative option for patients who resist biologic injection treatments due to a fear of needles. With this device, the manufacturer notes that patients never see the needle.
The autoinjector also features a safety needle cover that unlocks when one places the autoinjector firmly against the injection site. The manufacturer adds that two audible clicks signal the beginning and completion of the injection treatment.
The single-use device comes prefilled with a 50 mg/mL dose of Enbrel, according to the manufacturer. It notes that Enbrel is approved for treating moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, moderate to severe rheumatoid arthritis and moderate to severe juvenile rheumatoid arthritis.
Company: Amgen and Wyeth Pharmaceuticals
Product: Enbrel® Sureclick™ autoinjector
A Guide To Alternative Medicine
Have you seen your share of patients come into the office with questions about alternative treatment modalities for arthritis pain?
If so, one may want to check out An Alternative Medicine Definitive Guide: Arthritis (second edition).
The book, co-authored by Ellen Kamhi, PhD, RN, HNC, and Eugene R. Zampieron, ND, MH, offers chapters on diet, supplements and the roles of exercise and physical therapy, among other topics.
Publisher: Celestial Arts
Product: An Alternative Medicine Definitive Guide: Arthritis (second edition)
A New Approach To Invigorating Joints
Some patients suffering from osteoarthritis (OA) and joint pain may be uncomfortable with joint injections while other patients may not care for certain forms of oral medicine.
With this in mind, Lake Consumer Products offers Invigorate Joint Rejuvenating Products. Offering the option of either a fruity, chewable gel or a drinkable liquid, Invigorate Joint Rejuvenating Products combine the two ingredients of glucosamine and chondroitin, according to the company. The chewable gel also contains hydrated collagen.
The company says the products are designed to minimize joint discomfort and improve joint mobility. It adds that the combination of great taste and single dose should be appealing to seniors as well as children with arthritic conditions.
Company: Lake Consumer Products
Product: Invigorate Joint Rejuvenating Products
Editor’s note: Do you have a new product release? If so, please send it to Anthony Leone at aleone@hmpcommunications.com.
|
|
| Arthritis Practitioner - ISSN: 1 - Volume 2 - Issue 4 - July 2006 - Pages: 34 - | |
|
A complimentary CME Webcast Event
To register for this Web Archive program, click on Complimentary CME Webcast Event
This activity is for nurse practitioners, physician assistants, rheumatologists and internal medicine
physicians who treat patients with rheumatoid arthritis (RA).
Panelists/Lectures
"What You Should Know About Treating Early RA"
Nathan Wei, MD
Clinical Director
Arthritis and
Osteoporosis Center
Frederick, Md.
"A Closer Look At The Efficacy And Safety Of Combination Therapy With Anti-TNF Agents"
Philip Mease, MD
Clinical Professor
University of Washington
School of Medicine
Chief, Rheumatology Clinical Research
Swedish Hospital Medical Center
Seattle
"What The Studies Reveal About Emerging Therapies For RA"
Salahuddin Kazi, MD
Chief of Rheumatology
Presbyterian Hospital
Dallas,Tx.
This activity is supported by an educational grant from Genentech and Biogen Idec. The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).
A complimentary CME Webcast Event
ON DEMAND
(Q&A with panelists to follow lectures)
To register for this Webcast program, click on Complimentary CME Webcast
This activity is geared to physicians, rheumatologists, nurses, physician assistants and nurse practitioners who treat rheumatoid arthritis.
Agenda And Faculty
“Treating RA: The Shift To A More Aggressive Therapeutic Approach”
Linda Davis, MHS, PA-C
Assistant Professor
University Of North Texas Health Science Center
“What The Literature Reveals About Combination Therapy”
Kevin M. Latinis, MD, PhD
Division of Allergy, Clinical Immunology and Rheumatology
University of Kansas Medical Center
“New Biologic DMARDs: Can They Have An Impact?”
Salahuddin Kazi, MD
Chief of Rheumatology
Presbyterian Hospital
Dallas, Texas
This activity is supported by an educational grant from Bristol-Myers Squibb. The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).
A complimentary CME Web Archive Event
To register for this Web Archive program, click on Complimentary CME Web Archive Event
This activity is geared to physicians, nurses, physician assistants and nurse practitioners who treat osteoarthritis.
Agenda And Faculty
“A Closer Look At The Role Of Intraarticular Injections”
Frank Caruso, PA-C
Physician Assistant
Wake Forest University Baptist Medical Center
Winston-Salem, NC
“What The Literature Reveals About Viscosupplementation”
Nathan Wei, MD
Clinical Director
Arthritis and Osteoporosis Center
Frederick, MD
“Mastering The Technique Of Intraarticular Injections”
Mike Rudzinski, PA-C
Physician Assistant
Buffalo Veterans Affairs Medical Center
Buffalo, NY
This activity is supported by an educational grant from Genzyme.
The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).
A Complimentary CME Webcast Event
A Complimentary, On-Demand CME Webcast
To register for this Webcast program, click on Complimentary CME Webcast Event
This activity is geared to physicians, nurses, physician assistants and nurse practitioners who treat rheumatoid arthritis.
AGENDA and FACULTY
"Reviewing The Role of DMARDs In Treating RA"
Don Flinn, PA-C
Physician Assistant, McBride Clinic, Oklahoma City, Ok.
Vice-President, Society Of Physician Assistants In Rheumatology
"Assessing The Potential of Biologic Therapies"
Mark Genovese, MD
Associate Professor of Medicine
Division of Immunology And Rheumatology
Stanford University School Of Medicine
"What You Should Know About Infusion Therapy"
Nathan Wei, MD
Clinical Director
Arthritis and Osteoporosis Center
Frederick, Md.
This activity is supported by an educational grant from Bristol-Myers Squibb.
The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).
Educational Monographs
In a CME/CE roundtable discussion, expert panelists review the subtypes of JIA, keys to patient adherence and insights on treatments ranging from NSAIDs and methotrexate to emerging biologic agents.
This CME monograph is supported by an educational grant from Abbott Laboratories. It is sponsored by the North American Center for Continuing Medical Education (NACCME).
|
Emerging Concepts In Treating Rheumatoid Arthritis
A Guide To Viscosupplementation For Osteoarthritis Knee Pain
A Guide To Infusion Therapy For Patients With Rheumatoid Arthritis